Navamedic ASA (FRA:N1A)

Germany flag Germany · Delayed Price · Currency is EUR
1.825
0.00 (0.00%)
Last updated: Dec 4, 2025, 8:00 AM CET
-13.51%
Market Cap 44.03M
Revenue (ttm) 46.03M
Net Income (ttm) -3.23M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE 50.54
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 1.825
Previous Close 1.825
Day's Range 1.825 - 1.825
52-Week Range 1.490 - 2.400
Beta n/a
RSI 51.51
Earnings Date Apr 29, 2026

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propioni... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 42
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol N1A
Full Company Profile

Financial Performance

In 2024, Navamedic ASA's revenue was 531.44 million, an increase of 3.80% compared to the previous year's 512.00 million. Losses were -5.49 million, -59.92% less than in 2023.

Financial numbers in NOK Financial Statements

News

There is no news available yet.